Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
INTERVENTIONAL
Inicio: 14 de dic de 2020
ID: NCT04562766
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Amyloid Depleter ALXN2220 in Adult Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
INTERVENTIONAL
Inicio: 11 de ene de 2024
ID: NCT06183931
Completado
Fase 3
ClinicalTrials.gov
An International, Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization Procedures
INTERVENTIONAL
Inicio: 18 de ago de 2015
ID: NCT02504216
Completado
Fase 3
ClinicalTrials.gov
Six-month, Randomized, Open-label, Parallel-group Comparison of the Insulin Analog SAR342434 to Humalog® in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT02294474
Completado
Fase 3
ClinicalTrials.gov
A 36-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Including a 2 Year Extension Study to Evaluate Efficacy and Safety of Aliskiren on the Prevention of Left Ventricular Remodeling in High Risk Post-acute Myocardial Infarction Patients When Added to Optimized Standard Therapy
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00414609
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00677053
Completado
Fase 3
ClinicalTrials.gov
A 12 Week, Double-blind, Randomized, Parallel Group, Multi-center Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg Compared to Aliskiren 300 mg in Patients With Stage II Hypertension
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00705575
Completado
ClinicalTrials.gov
Risk Assessment of Ventilator-induced Lung Injury in Patients With Acute Respiratory Distress Syndrome: The Role of Morphological Phenotype in ARDS
OBSERVATIONAL
Inicio: 7 de ago de 2017
ID: NCT04157946
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab With or Without Bevacizumab Compared With Standard of Care as Firstline Maintenance Treatment for Participants With Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer With PD-L1 CPS Greater Than or Equal to 1 (TroFuse-036/GOG-3123/ENGOT-cx22)
INTERVENTIONAL
Inicio: 19 de ene de 2026
ID: NCT07216703
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
INTERVENTIONAL
Inicio: 3 de abr de 2023
ID: NCT05803421
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE-CONVERSION)
INTERVENTIONAL
Inicio: 1 de ago de 2016
ID: NCT02892149
Aún no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Single-arm, Open-label Extension Study to Evaluate the Safety of Finerenone in Addition to Standard of Care, in Pediatric Heart Failure Patients, From Birth to 18 Years of Age, With Left Ventricular Systolic Dysfunction (LVSD)
INTERVENTIONAL
Inicio: 1 de abr de 2026
ID: NCT07192952
Terminado
Fase 3
ClinicalTrials.gov
A Multi-center, Phase 3b, Stratified, Randomized, Open-label Clinical Trial to Evaluate the Efficacy of Intensive Apidra®/Lantus® Therapy vs Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects With Anterior STEMI (ST Elevation Myocardial Infarction) Undergoing PCI (Percutaneous Coronary Intervention)
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00670228
Reclutando
ClinicalTrials.gov
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures: An International Multicenter Prospective Study
OBSERVATIONAL
Inicio: 10 de mar de 2026
ID: NCT07027306
Completado
Fase 3
ClinicalTrials.gov
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
INTERVENTIONAL
Inicio: 29 de may de 2020
ID: NCT04255433
Reclutando
ClinicalTrials.gov
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
INTERVENTIONAL
Inicio: 11 de may de 2021
ID: NCT03206814
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the 6 Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality When Initiated Early After Hospitalization for Acute Decompensated Heart Failure
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00894387
Por invitación
ClinicalTrials.gov
EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV
OBSERVATIONAL
Inicio: 1 de ene de 1994
ID: NCT02699736
Completado
Fase 3
ClinicalTrials.gov
A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery
INTERVENTIONAL
Inicio: 1 de ene de 2013
ID: NCT01661101
Completado
Fase 3
ClinicalTrials.gov
Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure
INTERVENTIONAL
Inicio: 1 de sept de 2003
ID: NCT00071331
Anterior
1
...
33
34
35
...
434
Siguiente
Filtros